Kessinger A - Search Results

1

Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.

Vose JM, Sharp G, Chan WC, Nichols C, Loh K, Inwards D, Rifkin R, Bierman PJ, Lynch JC, Weisenburger DD, Kessinger A, Armitage JO. Vose JM, et al. Among authors: kessinger a. J Clin Oncol. 2002 May 1;20(9):2344-52. doi: 10.1200/JCO.2002.09.138. J Clin Oncol. 2002. PMID: 11981006 Clinical Trial.

2

Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.

Pavletic SZ, Smith LM, Bishop MR, Lynch JC, Tarantolo SR, Vose JM, Bierman PJ, Hadi A, Armitage JO, Kessinger A. Pavletic SZ, et al. Among authors: kessinger a. Am J Hematol. 2005 Apr;78(4):265-74. doi: 10.1002/ajh.20275. Am J Hematol. 2005. PMID: 15795914 Free article.

3

The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

Stewart DA, Vose JM, Weisenburger DD, Anderson JR, Ruby EI, Bast MA, Bierman PJ, Kessinger A, Armitage JO. Stewart DA, et al. Among authors: kessinger a. Ann Oncol. 1995 Mar;6(3):263-6. doi: 10.1093/oxfordjournals.annonc.a059156. Ann Oncol. 1995. PMID: 7612492 Free article.

4

Clinical outcome of peripheral blood stem cell support.

Kessinger A, Armitage J, Bierman P, Bishop M, Joshi S, Reed E, Sharp G, Talmadge J, Vose J. Kessinger A, et al. Med Oncol. 1994;11(2):43-6. doi: 10.1007/BF02988829. Med Oncol. 1994. PMID: 7850263 Review.

5

Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients.

Kessinger A, Vose JM, Bierman PJ, Bishop M, Armitage JO. Kessinger A, et al. J Hematother. 1993 Fall;2(3):361-2. doi: 10.1089/scd.1.1993.2.361. J Hematother. 1993. PMID: 7921996 Clinical Trial.

6

High-dose chemotherapy and autologous transplant with peripheral-blood stem cells.

Vose JM, Armitage JO, Kessinger A. Vose JM, et al. Among authors: kessinger a. Oncology (Williston Park). 1993 Aug;7(8):23-9; discussion 29-30, 33-4. Oncology (Williston Park). 1993. PMID: 8104456

7

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

Vose JM, Anderson JR, Kessinger A, Bierman PJ, Coccia P, Reed EC, Gordon B, Armitage JO. Vose JM, et al. Among authors: kessinger a. J Clin Oncol. 1993 Oct;11(10):1846-51. doi: 10.1200/JCO.1993.11.10.1846. J Clin Oncol. 1993. PMID: 8105034

8

High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.

Bierman PJ, Bagin RG, Jagannath S, Vose JM, Spitzer G, Kessinger A, Dicke KA, Armitage JO. Bierman PJ, et al. Among authors: kessinger a. Ann Oncol. 1993 Nov;4(9):767-73. doi: 10.1093/oxfordjournals.annonc.a058662. Ann Oncol. 1993. PMID: 8280658 Free article.

9

Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.

Vose JM, Reed EC, Pippert GC, Anderson JR, Bierman PJ, Kessinger A, Spinolo J, Armitage JO. Vose JM, et al. Among authors: kessinger a. J Clin Oncol. 1993 Jul;11(7):1306-10. doi: 10.1200/JCO.1993.11.7.1306. J Clin Oncol. 1993. PMID: 8315426 Clinical Trial.

10

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.

Sharp JG, Kessinger A, Mann S, Crouse DA, Armitage JO, Bierman P, Weisenburger DD. Sharp JG, et al. Among authors: kessinger a. J Clin Oncol. 1996 Jan;14(1):214-9. doi: 10.1200/JCO.1996.14.1.214. J Clin Oncol. 1996. PMID: 8558200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters